Center-Authored Papers

Filters: Author is Cella, David  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Ordoñana JR, Bartels M, Boomsma DI, Cella D, Mosing M, Oliveira JR, Patrick DL, Veenhoven R, Wagner GG, Sprangers MAG.  2012.  Biological pathways and genetic mechanisms involved in social functioning.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
C
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP et al..  2015.  Cancer-Related Fatigue, Version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(8):1012-39. Abstract
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
Moinpour CM, Donaldson GW, Davis KM, Potosky AL, Jensen RE, Gralow JR, Back AL, Hwang JJ, Yoon J, Bernard DL et al..  2016.  The challenge of measuring intra-individual change in fatigue during cancer treatment.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
D
Cella D, Rosenbloom SK, Beaumont JL, Yount SE, Paul D, Hampton D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn JH.  2011.  Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(3):268-78. Abstract
Lai J-S, Jensen SE, Beaumont JL, Abernethy AP, Jacobsen PB, Syrjala K, Raizer JJ, Cella D.  2014.  Development of a symptom index for patients with primary brain tumors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(1):62-9. Abstract
E
Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB et al..  2013.  Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.. Urologic oncology. Abstract
Pearman TP, Beaumont JL, Paul D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn J, Cella D.  2013.  Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).. Journal of pain and symptom management. 46(1):113-20. Abstract
I
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD et al..  2013.  ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
N
Jensen SE, Rosenbloom SK, Beaumont JL, Abernethy A, Jacobsen PB, Syrjala KL, Cella D.  2011.  A new index of priority symptoms in advanced ovarian cancer.. Gynecologic oncology. 120(2):214-9. Abstract
P
Hlubocky FJ, Webster K, Beaumont J, Cashy J, Paul D, Abernethy A, Syrjala KL, Von Roenn J, Cella D.  2013.  A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index.. Leukemia & lymphoma. 54(9):1942-6. Abstract
R
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D et al..  2012.  Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12):1371-7. Abstract
Jensen RE, Moinpour CM, Potosky AL, Lobo T, Hahn EA, Hays RD, Cella D, Smith AW, Wu X-C, Keegan THM et al..  2016.  Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort.. Cancer. Abstract
Jensen RE, Rothrock NE, DeWitt EM, Spiegel B, Tucker CA, Crane HM, Forrest CB, Patrick DL, Fredericksen R, Shulman LM et al..  2015.  The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.. Medical care. 53(2):153-9. Abstract
U
Jensen RE, Potosky AL, Moinpour CM, Lobo T, Cella D, Hahn EA, Thissen D, Smith AW, Ahn J, Luta G et al..  2017.  United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016714410. Abstract
V
Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, Smith AW, Keegan THM, Wu X-C, Paddock L et al..  2015.  Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 24(10):2333-44. Abstract